Musculoskeletal Diseases  >>  rivaroxaban  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivaroxaban / Generic mfg.
RECORD 3, NCT00361894 / 2005-004620-40: Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.

Completed
3
2531
Canada, Europe, RoW
Rivaroxaban (BAY59-7939), Enoxaparin
Bayer
Prevention, Venous Thromboembolism
01/07
01/07
RECORD 4, NCT00362232 / 2006-002402-60: Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.

Completed
3
3148
US, Canada, Europe, RoW
Rivaroxaban (Xarelto, BAY59-7939), Enoxaparin, Placebo: tablet of Rivaroxaban, Placebo: syringes of Enoxaparin
Bayer
Venous Thromboembolism
01/07
01/08
NCT01094886: Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

Completed
3
56
US
Rivaroxaban
Ortho-McNeil Janssen Scientific Affairs, LLC, Bayer
Arthritis, Osteoarthritis, Knee, Osteoarthritis, Hip, Thromboembolism
12/10
12/10
NCT01206972: Dose-confirmatory Bridging Study in Total Knee Replacement

Completed
3
302
Japan
Rivaroxaban (BAY59-7939), Enoxaparin
Bayer, Janssen Scientific Affairs, LLC
Venous Thromboembolism
05/11
06/11
HIP PRO Pilot, NCT05775965: HIP Fracture Oral thromboPROphylaxis (Hip PRO Pilot)

Not yet recruiting
3
250
Canada
Rivaroxaban 10mg, Rivaroxaban, acetylsalicylic acid (ASA) 81mg Oral Tablet, Aspirin
University of Calgary, Canadian Institutes of Health Research (CIHR)
Hip Fractures
03/25
03/26

Download Options